Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

The loss of α2β1 integrin suppresses joint inflammation and cartilage destruction in mouse models of rheumatoid arthritis.

Peters MA, Wendholt D, Strietholt S, Frank S, Pundt N, Korb-Pap A, Joosten LA, van den Berg WB, Kollias G, Eckes B, Pap T.

Arthritis Rheum. 2012 May;64(5):1359-68. doi: 10.1002/art.33487.

2.

Bone destruction in arthritis.

Gravallese EM.

Ann Rheum Dis. 2002 Nov;61 Suppl 2:ii84-6. Review.

3.

[Rheumatoid arthritis: new developments in the pathogenesis with special reference to synovial fibroblasts].

Seemayer CA, Distler O, Kuchen S, Müller-Ladner U, Michel BA, Neidhart M, Gay RE, Gay S.

Z Rheumatol. 2001 Oct;60(5):309-18. Review. German.

PMID:
11759230
4.

Fibroblast-like synoviocytes in inflammatory arthritis pathology: the emerging role of cadherin-11.

Chang SK, Gu Z, Brenner MB.

Immunol Rev. 2010 Jan;233(1):256-66. doi: 10.1111/j.0105-2896.2009.00854.x. Review.

PMID:
20193004
5.

Joint inflammation and cartilage destruction may occur uncoupled.

van den Berg WB.

Springer Semin Immunopathol. 1998;20(1-2):149-64. Review.

PMID:
9836374
6.

The role of cytokines in osteoarthritis pathophysiology.

Fernandes JC, Martel-Pelletier J, Pelletier JP.

Biorheology. 2002;39(1-2):237-46. Review.

PMID:
12082286
7.

Stable activation of fibroblasts in rheumatic arthritis-causes and consequences.

Korb-Pap A, Bertrand J, Sherwood J, Pap T.

Rheumatology (Oxford). 2016 Dec;55(suppl 2):ii64-ii67. Review.

PMID:
27856663
8.

Pathogenesis of joint damage in rheumatoid arthritis: evidence of a dominant role for interleukin-I.

van den Berg WB, Bresnihan B.

Baillieres Best Pract Res Clin Rheumatol. 1999 Dec;13(4):577-97. Review.

PMID:
10652641
9.

Amplifying elements of arthritis and joint destruction.

van den Berg WB, van Lent PL, Joosten LA, Abdollahi-Roodsaz S, Koenders MI.

Ann Rheum Dis. 2007 Nov;66 Suppl 3:iii45-8. Review.

10.

Integrins and their ligands in rheumatoid arthritis.

Lowin T, Straub RH.

Arthritis Res Ther. 2011;13(5):244. doi: 10.1186/ar3464. Epub 2011 Oct 28. Review.

11.

Cellular basis and oncogene expression of rheumatoid joint destruction.

Gay S, Gay RE.

Rheumatol Int. 1989;9(3-5):105-13. Review.

PMID:
2692124
12.

Aging mechanisms in arthritic disease.

Sacitharan PK, Snelling SJ, Edwards JR.

Discov Med. 2012 Nov;14(78):345-52. Review.

13.

Mouse Models of Rheumatoid Arthritis.

Caplazi P, Baca M, Barck K, Carano RA, DeVoss J, Lee WP, Bolon B, Diehl L.

Vet Pathol. 2015 Sep;52(5):819-26. doi: 10.1177/0300985815588612. Epub 2015 Jun 10. Review.

PMID:
26063174
14.

Animal models of rheumatoid arthritis and related inflammation.

Joe B, Griffiths MM, Remmers EF, Wilder RL.

Curr Rheumatol Rep. 1999 Dec;1(2):139-48. Review.

PMID:
11123028
15.

Osteopontin: a bridge between bone and the immune system.

Gravallese EM.

J Clin Invest. 2003 Jul;112(2):147-9. Review. Erratum in: J Clin Invest. 2003 Aug;112(4):627.

16.

Cellular and molecular pathways of structural damage in rheumatoid arthritis.

Harre U, Schett G.

Semin Immunopathol. 2017 Jun;39(4):355-363. doi: 10.1007/s00281-017-0634-0. Epub 2017 Jun 8. Review.

PMID:
28597065
17.

Lessons from animal models of arthritis over the past decade.

van den Berg WB.

Arthritis Res Ther. 2009;11(5):250. doi: 10.1186/ar2803. Epub 2009 Oct 14. Review.

18.

Angiopoietin-like 4: A molecular link between insulin resistance and rheumatoid arthritis.

Masuko K.

J Orthop Res. 2017 May;35(5):939-943. doi: 10.1002/jor.23507. Epub 2017 Mar 8. Review.

PMID:
28004425

Supplemental Content

Support Center